C86.40 Faturalandırılabilir, belirli kod Blastic NK-cell lymphoma not having achieved remission

ICD-10-CM C86.40 identifies “Blastic NK-cell lymphoma not having achieved remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Bölüm 2: Neoplasms

Kod talimatları

Inclusion terms5
  • Blastic NK-cell lymphoma NOS
  • Blastic NK-cell lymphoma with failed remission
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) NOS
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) not having achieved remission
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) with failed remission

Üst düzey talimatlar

Bölümler 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C86 · Other specified types of T/NK-cell lymphoma

Excludes 14
  • anaplastic large cell lymphoma, ALK negative (C84.7-)
  • anaplastic large cell lymphoma, ALK positive (C84.6-)
  • mature T/NK-cell lymphomas (C84.-)
  • other specified types of non-Hodgkin lymphoma (C85.8-)

C86.4 · Blastic NK-cell lymphoma

Inclusion terms1

Blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Resmî dizin referansları

Resmî dönüşüm geçmişi

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Geçerlilik tarihleri 2024-10-01

Önceki atama: C86.4

Diğer kodlardan atıflar (1)
Geçmiş

Kod geçmişi

Son kaydedilen değişiklik · FY2025

DeğiştiDeğişmedi
FY2025

Yürürlük tarihi

  • Eklendi

Blastic NK-cell lymphoma not having achieved remission

Faturalanabilir tanı kodu

CDC/NCHS · FY2025

Tüm sürümler (5)

Tüm sürümlerYürürlük tarihiKod geçmişi
FY20252024-10-01Eklendi
FY2025 · 04-012025-04-01Tabloda değişiklik yok
FY20262025-10-01Tabloda değişiklik yok
FY2026 · April2026-04-01Tabloda değişiklik yok
FY20272026-10-01Tabloda değişiklik yok

Bu girdi, seçilen sürümde tam bir koddur. Referans kontrolü klinik uygunluğu belirlemez veya geri ödemeyi garanti etmez.